Jillian E Halladay1, Michael H Boyle2, Catharine Munn3, Susan M Jack4, Katholiki Georgiades5. 1. 1 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. 2. 2 Department of Health Research Methods, Evidence, and Impact, Psychiatry & Behavioural Neurosciences, Offord Centre for Child Studies, McMaster University, Hamilton, Ontario, Canada. 3. 3 Department of Psychiatry and Behavioural Neurosciences, Peter Boris Centre for Addictions Research, McMaster University, Hamilton, Ontario, Canada. 4. 4 Department of Health Research Methods, Evidence, and Impact, School of Nursing, Offord Centre for Child Studies, McMaster University, Hamilton, Ontario, Canada. 5. 5 Department of Health Research Methods, Evidence, and Impact, David R. (Dan) Offord Chair in Child Studies, Psychiatry & Behavioural Neurosciences, Offord Centre for Child Studies, McMaster University, Hamilton, Ontario, Canada.
Abstract
BACKGROUND: Depression, anxiety, and substance use disorders are leading causes of morbidity worldwide. The most commonly used illicit substance is cannabis and there is some evidence that the association between cannabis use and poor mental health is more pronounced among females compared with males. This analysis examines sex differences in the association between cannabis use and major depressive episode (MDE), suicidal thoughts and attempts, and psychological distress. METHODS: This study uses data from the 2002 and 2012 Canadian Community Health Survey's Mental Health Component, repeated cross-sectional surveys of nationally representative samples of Canadians 15 years of age and older ( n = 43,466). Linear and binary logistic regressions were performed, applying weighting and bootstrapping. RESULTS: There were significant sex differences in the strength of the association between cannabis use and suicidal thoughts and attempts and psychological distress, but not MDE. Females who reported using cannabis occasionally (defined as 1 to 4 times a month) reported higher levels of psychological distress than their male counterparts. Females who reported using regularly (defined as more than once per week) reported higher levels of psychological distress and were more likely to report suicidal thoughts and attempts. CONCLUSIONS: Future research is needed to further our understanding of the nature of these sex differences. Public health messaging should incorporate being female as a potential risk factor for the co-occurrence of cannabis use and emotional problems, particularly at higher frequencies of use. Clinicians should also be aware of this association to better inform integrated mental health and substance use screening, discussions, and care, particularly for female patients.
BACKGROUND:Depression, anxiety, and substance use disorders are leading causes of morbidity worldwide. The most commonly used illicit substance is cannabis and there is some evidence that the association between cannabis use and poor mental health is more pronounced among females compared with males. This analysis examines sex differences in the association between cannabis use and major depressive episode (MDE), suicidal thoughts and attempts, and psychological distress. METHODS: This study uses data from the 2002 and 2012 Canadian Community Health Survey's Mental Health Component, repeated cross-sectional surveys of nationally representative samples of Canadians 15 years of age and older ( n = 43,466). Linear and binary logistic regressions were performed, applying weighting and bootstrapping. RESULTS: There were significant sex differences in the strength of the association between cannabis use and suicidal thoughts and attempts and psychological distress, but not MDE. Females who reported using cannabis occasionally (defined as 1 to 4 times a month) reported higher levels of psychological distress than their male counterparts. Females who reported using regularly (defined as more than once per week) reported higher levels of psychological distress and were more likely to report suicidal thoughts and attempts. CONCLUSIONS: Future research is needed to further our understanding of the nature of these sex differences. Public health messaging should incorporate being female as a potential risk factor for the co-occurrence of cannabis use and emotional problems, particularly at higher frequencies of use. Clinicians should also be aware of this association to better inform integrated mental health and substance use screening, discussions, and care, particularly for female patients.
Authors: Brian Rush; Karen Urbanoski; Diego Bassani; Saulo Castel; T Cameron Wild; Carol Strike; Dennis Kimberley; Julian Somers Journal: Can J Psychiatry Date: 2008-12 Impact factor: 4.356
Authors: Tod E Kippin; Rita A Fuchs; Ritu H Mehta; Jordan M Case; Macon P Parker; Heather A Bimonte-Nelson; Ronald E See Journal: Psychopharmacology (Berl) Date: 2005-10-19 Impact factor: 4.530
Authors: Deborah A Dawson; Risë B Goldstein; Howard B Moss; Ting-Kai Li; Bridget F Grant Journal: Drug Alcohol Depend Date: 2010-06-16 Impact factor: 4.492
Authors: Jillian E Halladay; Catharine Munn; Michael Boyle; Susan M Jack; Katholiki Georgiades Journal: Can J Psychiatry Date: 2019-06-09 Impact factor: 4.356
Authors: Jessica M Round; Cerina Lee; John G Hanlon; Elaine Hyshka; Jason R B Dyck; Dean T Eurich Journal: BMC Public Health Date: 2020-06-23 Impact factor: 3.295
Authors: Maria Gloria Rossetti; Scott Mackey; Praveetha Patalay; Nicholas B Allen; Albert Batalla; Marcella Bellani; Yann Chye; Patricia Conrod; Janna Cousijn; Hugh Garavan; Anna E Goudriaan; Robert Hester; Rocio Martin-Santos; Nadia Solowij; Chao Suo; Paul M Thompson; Murat Yücel; Paolo Brambilla; Valentina Lorenzetti Journal: Transl Psychiatry Date: 2021-05-06 Impact factor: 6.222